Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) hit a new 52-week low on Friday . The stock traded as low as $10.12 and last traded at $10.21, with a volume of 1907894 shares. The stock ...

Within a few days, I was shunted out of the hospital with some meds, and pamphlets and told by a cardiologist who looked and ...

Initiate pivotal studies for NX-5948: Nurix is evaluating NX-5948 in an ongoing Phase 1b clinical trial in adults with relapsed or refractory B-cell malignancies and expects to initiate a suite of ...

Initiate a suite of clinical trials in 2025 intended to support global registration of NX-5948 for the treatment of chronic lymphocytic ...

Agios Pharma submitted a sNDA to the FDA after two Phase III trials studying PYRUKYND (mitapivat) in thalassemia met their ...

Expresses differences in erythrocyte size in an individual specimen Used to detect anisocytosis. Increased in immune hemolytic anemia, SS and SC disease, and hereditary spherocytosis ...

Shares of Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) have been given an average rating of “Moderate Buy” by the ten ...

Postnatal treatment approaches to hemolytic disease of the fetus and newborn vary significantly ... adding blood or blood ...

Valleant’s recently released guide aims to help individuals better understand anemia, explore treatment options, and offer nutritional and lifestyle advice to support the management of ...